The biotech company also has a partnership with Sanofi (SNY) for the development, manufacture and commercialization of IgM antibody agonists against inflammation and immunology targets.

Topline data were announced from a phase 2/3 trial evaluating immune globulin intravenous (human) in patients with post-polio syndrome.

The firm’s product pipeline includes IGM-2323, which is a CD20 x CD3 bispecific IgM antibody designed to treat patients with B cell Non-Hodgkin's lymphoma and other B cell malignancies ...

High antibody titers of anti–citrullinated peptide antibodies, rheumatoid factor, and certain baseline factors predict RA ...

Gut IgA functionally interacts with systemic IgG to enhance antipneumococcal vaccine responses. Science Advances , 2025; 11 (7) DOI: 10.1126/sciadv.ado9455 Cite This Page : ...

Under these changes, it will halt further development of imvotamab, an IgM-based CD20 X CD3 bispecific antibody T cell engager, and IGM-2644, an IgM-based CD38 X CD3 bispecific antibody T cell ...

Serum was stored at −80°C. IgM, IgD, IgA, IgG, IgG1, 2, 3, and 4, and total IgE were measured. Results: The following immunoglobulins were significantly (p⩽0.05) altered after the race: IgD, ...

Molecular diagnosis of HAV along with anti-HAV IgG avidity measurement are helpful in case of positive IgM where laboratory evidence of acute hepatitis is absent and there is no epidemiologic link ...